Candel Therapeutics, Inc. (CADL)

Candel Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	16.56	35.41	70.06	82.64	35.05	5.18
Short-Term Investments	-	-	-	-	-	39.88
Cash & Short-Term Investments	16.56	35.41	70.06	82.64	35.05	45.06
Cash Growth	-61.48%	-49.45%	-15.23%	135.76%	-22.20%	-
Prepaid Expenses	1.53	1.38	1.89	2.3	0.09	0.15
Total Current Assets	18.09	36.8	71.95	84.95	35.15	45.21
Property, Plant & Equipment	3.09	4.02	5.48	3.84	2.79	0.43
Other Long-Term Assets	0.34	0.38	0.27	0.42	0.35	0.27
Total Assets	21.52	41.2	77.69	89.21	38.28	45.9
Accounts Payable	0.3	0.42	0.38	1.59	0.92	0.22
Accrued Expenses	4.57	4.36	4.72	3.44	3.14	1.07
Short-Term Debt	-	-	-	-	0.46	-
Current Portion of Long-Term Debt	9.85	8.89	-	-	-	-
Current Portion of Leases	0.55	0.51	0.46	-	-	-
Other Current Liabilities	-	-	0.05	0.33	0.19	0.13
Total Current Liabilities	15.27	14.18	5.62	5.36	4.71	1.41
Long-Term Debt	5.07	12.38	20.85	0.56	0.48	0.42
Long-Term Leases	0.56	0.97	1.49	-	-	-
Long-Term Unearned Revenue	-	-	0.14	-	0.13	0.25
Other Long-Term Liabilities	15.89	0.92	1.88	19.15	7.46	2.8
Total Liabilities	36.77	28.46	29.98	25.07	12.78	4.88
Common Stock	0.32	0.29	0.29	0.29	0.12	0.29
Additional Paid-In Capital	163	149.93	146.96	144.15	20.49	18.19
Retained Earnings	-178.13	-137.03	-99.09	-80.3	-44.17	-26.49
Treasury Stock	-0.45	-0.45	-0.45	-	-	-
Comprehensive Income & Other	-	-	-	-	-	-0.02
Total Common Equity	-15.26	12.75	47.71	64.14	-23.56	-8.04
Shareholders' Equity	-15.26	12.75	47.71	64.14	25.5	41.02
Total Liabilities & Equity	21.52	41.2	77.69	89.21	38.28	45.9
Total Debt	16.02	22.76	22.8	0.56	0.95	0.42
Net Cash (Debt)	0.54	12.65	47.26	82.08	34.11	44.64
Net Cash Growth	-97.35%	-73.23%	-42.43%	140.66%	-23.59%	-
Net Cash Per Share	0.02	0.44	1.64	4.35	2.94	3.87
Filing Date Shares Outstanding	32.48	29.35	28.92	28.69	11.64	11.64
Total Common Shares Outstanding	32.13	29.09	28.92	28.69	11.64	11.61
Working Capital	2.82	22.61	66.33	79.58	30.43	43.8
Book Value Per Share	-0.47	0.44	1.65	2.24	-2.03	-0.69
Tangible Book Value	-15.26	12.75	47.71	64.14	-23.56	-8.04
Tangible Book Value Per Share	-0.47	0.44	1.65	2.24	-2.03	-0.69
Machinery	2.2	2.19	2.5	1.19	1.4	0.15
Construction In Progress	-	-	-	-	1.22	-
Leasehold Improvements	3.11	3.11	3.06	2.99	0.31	0.31

Source: S&P Capital IQ. Standard template. Financial Sources.